In Vitro Synergism of Rifabutin with Clarithromycin, Imipenem, and Tigecycline against the Mycobacterium abscessus Complex

Infections caused by the difficult-to-treat bacterium Mycobacterium abscessus are increasing in frequency. Rifabutin, in contrast to rifampin, appears to be active in vitro against M. abscessus, especially against clarithromycin-resistant strains. However, explorations for potential synergy between...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Antimicrob Agents Chemother
Main Authors: Cheng, Aristine, Tsai, Yi-Tzu, Chang, Shu-Yuan, Sun, Hsin-Yun, Wu, Un-In, Sheng, Wang-Huei, Chen, Yee-Chun, Chang, Shan-Chwen
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology 2019
נושאים:
Susceptibility
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437537/
https://ncbi.nlm.nih.gov/pubmed/30670428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02234-18
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים